JP2024508597A5 - - Google Patents

Info

Publication number
JP2024508597A5
JP2024508597A5 JP2023541591A JP2023541591A JP2024508597A5 JP 2024508597 A5 JP2024508597 A5 JP 2024508597A5 JP 2023541591 A JP2023541591 A JP 2023541591A JP 2023541591 A JP2023541591 A JP 2023541591A JP 2024508597 A5 JP2024508597 A5 JP 2024508597A5
Authority
JP
Japan
Application number
JP2023541591A
Other languages
Japanese (ja)
Other versions
JPWO2022188652A5 (https=
JP2024508597A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/078327 external-priority patent/WO2022188652A1/zh
Publication of JP2024508597A publication Critical patent/JP2024508597A/ja
Publication of JPWO2022188652A5 publication Critical patent/JPWO2022188652A5/ja
Publication of JP2024508597A5 publication Critical patent/JP2024508597A5/ja
Pending legal-status Critical Current

Links

JP2023541591A 2021-03-09 2022-02-28 Ror1結合タンパク質及びその用途 Pending JP2024508597A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110255430.8 2021-03-09
CN202110255430 2021-03-09
PCT/CN2022/078327 WO2022188652A1 (zh) 2021-03-09 2022-02-28 Ror1结合蛋白及其用途

Publications (3)

Publication Number Publication Date
JP2024508597A JP2024508597A (ja) 2024-02-28
JPWO2022188652A5 JPWO2022188652A5 (https=) 2025-03-06
JP2024508597A5 true JP2024508597A5 (https=) 2025-03-06

Family

ID=83226356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541591A Pending JP2024508597A (ja) 2021-03-09 2022-02-28 Ror1結合タンパク質及びその用途

Country Status (8)

Country Link
US (1) US20240018237A1 (https=)
EP (1) EP4306540A4 (https=)
JP (1) JP2024508597A (https=)
KR (1) KR20230156021A (https=)
CN (1) CN116829599A (https=)
CA (1) CA3207635A1 (https=)
MX (1) MX2023008176A (https=)
WO (1) WO2022188652A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022227686A1 (en) 2021-02-25 2023-07-27 Lyell Immunopharma, Inc. Ror1 targeting chimeric antigen receptor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CN1487996B (zh) 2000-11-30 2010-06-16 米德列斯公司 用于生产人类抗体的转基因转染色体啮齿动物
US9758586B2 (en) * 2010-12-01 2017-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric rabbit/human ROR1 antibodies
DK3252076T3 (da) 2011-01-14 2019-12-02 Univ California Diagnostisk anvendelse af antistoffer mod ror-1-protein
KR102236367B1 (ko) 2013-07-26 2021-04-05 삼성전자주식회사 DARPin을 포함하는 이중 특이 키메라 단백질
US10323095B2 (en) 2014-03-17 2019-06-18 Mitsubishi Tanabe Pharma Corporation Antibody-fynomer conjugates
CN105924533B (zh) * 2016-07-13 2020-04-21 北京康爱瑞浩生物科技股份有限公司 Ror1特异性嵌合抗原受体及其应用
MX2019015057A (es) * 2017-06-23 2020-08-03 Velosbio Inc Inmunoconjugados de anticuerpos receptor huérfano similar al receptor tirosina cinasa 1 (ror1).
CN109836498A (zh) * 2017-11-25 2019-06-04 深圳宾德生物技术有限公司 一种靶向ror1的单链抗体、嵌合抗原受体t细胞及其制备方法和应用
GB201721802D0 (en) * 2017-12-22 2018-02-07 Almac Discovery Ltd Ror1-specific antigen binding molecules
CN108441505B (zh) * 2018-05-28 2023-07-07 上海恒润达生生物科技股份有限公司 一种靶向ror1的嵌合抗原受体及其用途
EP3820484A4 (en) * 2018-07-10 2022-05-04 Precigen, Inc. ROR-1 SPECIFIC CHIMERA ANTIGEN RECEPTORS AND USES THEREOF
CA3123303A1 (en) * 2019-01-29 2020-08-06 Juno Therapeutics, Inc. Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024508597A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13155U (https=)
BY13140U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
BY13160U (https=)
BY13159U (https=)
BY13158U (https=)
BY13157U (https=)
BY13156U (https=)
BY13170U (https=)